iRhythm Technologies (IRTC)

• Market cap: $3.36B
• 1 day: 2.10%
• 5 days: 0.35%
• 1 month: -2.03%
• 3 months: 19.50%
• 6 months: 49.32%
• Year to date: 19.50%
• 1 year: -7.50%
• 5 years: 42.49%
• 10 years: 310.29%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 2 (+1) [Q4]

20% more capital invested

Capital invested by funds: $2.61B [Q3] → $3.14B (+$529M) [Q4]

1.38% more ownership

Funds ownership: 112.69% [Q3] → 114.07% (+1.38%) [Q4]

6% less funds holding

Funds holding: 238 [Q3] → 223 (-15) [Q4]

10% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 80

24% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 51

56% less call options, than puts

Call options by funds: $11.4M | Put options by funds: $25.8M

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $104 3% downside
• Avg. target: $126 18% upside
• High target: $145 36% upside

5 analyst ratings

• positive: 3 60%
• neutral: 2 40%
• negative: 0 0%

Goldman Sachs David Roman 30% 1-year accuracy 6 / 20 met price target	16% upside $124	Neutral Maintained	24 Feb 2025
Truist Securities Richard Newitter 51% 1-year accuracy 22 / 43 met price target	36% upside $145	Buy Maintained	21 Feb 2025
Wells Fargo Nathan Treybeck 25% 1-year accuracy 1 / 4 met price target	3% downside $104	Equal-Weight Maintained	21 Feb 2025
Needham David Saxon 37% 1-year accuracy 24 / 65 met price target	29% upside $138	Buy Maintained	21 Feb 2025
Oppenheimer Suraj Kalia 38% 1-year accuracy 8 / 21 met price target	12% upside $120	Outperform Maintained	8 Jan 2025